Answer
Caution and monitoring for adverse reactions are advised when momelotinib is taken with ciclosporin, an OATP1B1/1B3 inhibitor, because inhibition of these transporters may increase momelotinib exposure.
Sources for this answer
- Omjjara 150 mg film-coated tabletsGlaxoSmithKline UK · emc · SmPC §4.5 Interaction with other medicinal products · Version 4Document updated
Sources checked